Whereas LRRK2 mutation carriers with Parkinson's disease reveal impaired presynaptic dopamine function (Nandhagopal et al. 2008), clinically asymptomatic, otherwise, healthy, mutations carriers reveal early increases in dopamine turnover by PET imaging (Sossi et al. 2010). This evidence concerns the gene LRRK2 and Parkinson disease.